Chemoprevention trials and surrogate end point biomarkers in the cervix
- 15 November 1995
- Vol. 76 (S10) , 1956-1977
- https://doi.org/10.1002/1097-0142(19951115)76:10+<1956::aid-cncr2820761312>3.0.co;2-v
Abstract
No abstract availableKeywords
This publication has 106 references indexed in Scilit:
- Chemoprevention of cancerThe Lancet, 1993
- Immunohistochemical analysis of p53 protein overexpression in normal, premalignant, and malignant tissues of the cervix uteriThe Journal of Pathology, 1993
- Morphometric Distinction of Sclerosing Adenosis from Tubular Carcinoma of the BreastPathology - Research and Practice, 1992
- Chemoprevention clinical trialsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1992
- Human Papillomavirus Infection of the CervixObstetrics & Gynecology, 1992
- Retinoic acid suppression of squamous differentiation in human head-and-neck squamous carcinoma cellsInternational Journal of Cancer, 1991
- Plasma levels of antioxidantβ‐carotene and α‐tocopherol in uterine cervix dysplasias and cancerNutrition and Cancer, 1991
- Gastrointestinal tissue diagnosis by laser-induced fluorescence spectroscopy at endoscopyGastrointestinal Endoscopy, 1990
- Diet and Cancer — An OverviewNew England Journal of Medicine, 1984
- Diet and Cancer – An OverviewNew England Journal of Medicine, 1984